Endoglin (CD105), a receptor of the transforming growth factor-beta superfamily, is
considered a powerful marker of angiogenesis and a potential main player in the …

Abstract Endoglin (CD105), a receptor of the transforming growth factor-β superfamily, has
been reported to identify functional long-term repopulating hematopoietic stem cells, and …

I read with interest the report of Balza et al. 1 describing the expression of endoglin (EDG) in
human tissues and cultured cell lines using a new monoclonal antibody termed A11 …

Targeting of tumor vasculature is a promising strategy for cancer treatment. Among
endothelial cell markers, Endoglin, a cell membrane glycoprotein, is emerging as an …

Abstract 3826 Endoglin (EDG; CD105) is a cell membrane antigen that was initially
identified as a human leukemia-associated homodimeric glycoprotein. EDG is a proliferation …

Angiogenesis is crucial for tumor development and progression, and antiangiogenetic
therapy represents a promising approach for cancer treatment. Thus, the in-depth …

Endoglin (CD105) is a cell membrane glycoprotein over‐expressed on highly proliferating
endothelial cells in culture, and on endothelial cells of angiogenetic blood vessels within …

Endoglin (CD 105) is a cell surface antigen widely expressed on vascular endothelium,
syncytiotrophoblast, some tissue macrophages, certain culture cells (including early …

Among surface molecules expressed on endothelial cells, endoglin (CD105) is emerging as
a prime vascular target for antiangiogenetic cancer therapy. CD105 is a cell membrane …

Increasing evidence suggests that endoglin (CD105) is a new powerful marker of
neovascularization in solid malignancies; thus, using breast cancer as a model, we …